Intrinsic Value of S&P & Nasdaq Contact Us

CareDx, Inc CDNA NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
60/100
3/7 Pass
SharesGrow Intrinsic Value
$629.37
+3469.9%
Analyst Price Target
$23.33
+32.3%

CareDx, Inc (CDNA) is a publicly traded company in the Healthcare sector, operating within the Medical - Diagnostics & Research industry. The company is headquartered in South San Francisco, CA, United States. The current CEO is John Walter Hanna Jr..

CDNA has IPO date of 2014-07-17, 644 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $906.76M.

About CareDx, Inc

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

📍 1 Tower Place, South San Francisco, CA 94080 📞 415 287 2300
Company Details
SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryUnited States
ExchangeNASDAQ Global Market
CurrencyUSD
IPO Date2014-07-17
CEOJohn Walter Hanna Jr.
Employees644
Trading Info
Current Price$17.63
Market Cap$906.76M
52-Week Range10.96-21.485
Beta2.54
ETFNo
ADRNo
CUSIP14167L103
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message